Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01407939 · ClinicalTrials.gov registry record

Efficacy of Bitter Blockers on Taste Perception in Children and Adults

A clinical trial, sponsored by Monell Chemical Senses Center.

Completed
Registry status
215
Enrollment target

NCT01407939 is a clinical trial that has completed, run by Monell Chemical Senses Center. The registered enrollment target is 215 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01407939 has completed, sponsored by Monell Chemical Senses Center.

COMPLETED
Registry status
215 participants
Enrollment target

Study Summary

This proposal describes 2 basic research studies that will be conducted sequentially. Study 1 will test the efficacy of both classic and newly developed "generally recognized as a safe" (GRAS) bitter blockers on the perceived bitterness and acceptance of different classes of bitter-tasting compounds by children and compare their responses to adults. Because variations among and between children and adults in terms of sensitivity to different bitter compounds are due in part to genetically determined receptor variation, the investigators will consider genotype when assessing how well bitter blockers perform. In Study 2, the investigators aim to evaluate different methods (forced-choice procedures, hedonic face scales) used for testing children to determine their reliability and reproducibility.

Trial Details

FieldValue
Enrollment Target 215 participants
Start Date 2011-04
Est. Completion 2016-03

Sponsor

Monell Chemical Senses Center

16 total trials

What the Registry Record Tells You About NCT01407939

The ClinicalTrials.gov registry entry for NCT01407939 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 215 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Monell Chemical Senses Center, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01407939 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01407939 about?

NCT01407939 is a clinical study titled "Efficacy of Bitter Blockers on Taste Perception in Children and Adults". This proposal describes 2 basic research studies that will be conducted sequentially. Study 1 will test the efficacy of both classic and newly developed "generally recognized as a safe" (GRAS) bitter blockers on the perceived bitterness and acceptance of different classes of bitter-tasting compounds...

What is the current status of trial NCT01407939?

This trial is currently completed. The enrollment target is 215 participants. The study started on 2011-04. Estimated completion is 2016-03.

Who is sponsoring clinical trial NCT01407939?

This trial is sponsored by Monell Chemical Senses Center, which has 16 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.